Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Cell Host & Microbe · 2023-05 · 31 (5) · 712-733
DOI: 10.1016/j.chom.2023.03.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2023-05. Verfasst von Serena Porcari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Depa…. Hauptthemen laut MEDLINE: Clostridioides difficile, Microbiota, Gastrointestinal Microbiome, Clostridium Infections. Die Arbeit wurde bisher 346-mal zitiert (Crossref) und nennt 149 Literaturangaben.
Abstract (Originalsprache)
Fecal microbiota transplantation (FMT) has achieved satisfactory results in preventing the recurrence of Clostridioides difficile infection, but these positive outcomes have only been partially replicated in other diseases. Several factors influence FMT success, including those related to donors and recipients (including diversity and specific composition of the gut microbiome, immune system, and host genetics) as well as to working protocols (fecal amount and number of infusions, route of delivery, and adjuvant treatments). Moreover, initial evidence suggests that the clinical success of FMT may be related to the degree of donor microbial engraftment. The application of cutting-edge technologies for microbiome assessment, along with changes in the current vision of fecal transplants, are expected to improve FMT protocols and outcomes. Here, we review the key determinants of FMT success and insights and strategies that will enable a close integration of lab-based and clinical approaches for increasing FMT success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Translational Medicine and Surgery, Università Cattolica del…
- Hospices Civils de Lyon, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), Inserm U1052, CNRS UMR 5286, Lyon, France; F…
- Department CIBIO, University of Trento, Trento, Italy.
- Department CIBIO, University of Trento, Trento, Italy; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
- French Fecal Transplant Group (GFTF), France; Sorbonne University, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Saint Antoine Hospital, Gastroenterology Department, Paris, France; Paris Centre for Microbiome…
Zitieren
APA
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023). Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host & Microbe, 31(5), 712-733. https://doi.org/10.1016/j.chom.2023.03.020
Vancouver
Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host & Microbe. 2023;31(5):712-733. doi:10.1016/j.chom.2023.03.020
BibTeX
@article{Porcari2023,
author = {Porcari, Serena and Benech, Nicolas and Valles-Colomer, Mireia and Segata, Nicola and Gasbarrini, Antonio and Cammarota, Giovanni and Sokol, Harry and Ianiro, Gianluca},
title = {Key determinants of success in fecal microbiota transplantation: From microbiome to clinic},
journal = {Cell Host & Microbe},
year = {2023},
volume = {31},
number = {5},
pages = {712--733},
doi = {10.1016/j.chom.2023.03.020}
}
EUVIMED